Indoco Remedies has received accreditation renewal, from Japanese regulatory authorities.
The company is a fully integrated, research oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).
Furthermore, the company’s API plant which is located at Patalganga, has received accreditation renewal from the Japanese regulatory authorities. The accreditation is valid until May 21,2023.
